SCHEMBL19902550

SCHEMBL19902550

CCC(=O)c1cnn2cc(N3CC(F)C3)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.36
KCNH2 Q12809 1/20 0.35
SLC27A1 Q6PCB7 1/20 0.33
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 4/20 0.32
HSD17B10 Q99714 3/20 0.32
USP30 Q70CQ3 1/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
EPHB3 P54753 2/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
LRRK2 Q5S007 1/20 0.32
PLAT P00750 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KLF5 Q13887 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19902684 0.92 ROCK2 (0.36) ROCK2KCNH2SLC27A1KDM4EALDH1A1
SCHEMBL19902552 0.92 ROCK2 (0.36) ROCK2KCNH2SLC27A1KDM4EALDH1A1
SCHEMBL17454457 0.87 ROCK2 (0.36) ROCK2KCNH2KDM4EALDH1A1HSD17B10
SCHEMBL17437916 0.85 KEAP1 (0.35) ROCK2ALDH1A1USP30EPHB3DRD4
SCHEMBL19902388 0.84 HTT (0.44) ROCK2KCNH2SLC27A1KDM4EALDH1A1
SCHEMBL19902678 0.83 ROCK2 (0.38) ROCK2KCNH2SLC27A1KDM4EALDH1A1
SCHEMBL31165565 0.83 ROCK2 (0.38) ROCK2KDM4EUSP30TSHREPHB3
SCHEMBL17452631 0.83 ROCK2 (0.34) ROCK2USP30EPHB3IRAK4
SCHEMBL19902576 0.81 ROCK2 (0.48) ROCK2KDM4EDRD4DRD3NPC1
SCHEMBL23889078 0.81 ROCK2 (0.39) ROCK2KCNH2SLC27A1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902702-B2 Spirocycloheptanes as inhibitors of rock BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-27 US disclosed